نتایج جستجو برای: ssc startup

تعداد نتایج: 8269  

2016
Swati Bhattacharyya Wenxia Wang Luisa Morales-Nebreda Gang Feng Minghua Wu Xiaodong Zhou Robert Lafyatis Jungwha Lee Monique Hinchcliff Carol Feghali-Bostwick Katja Lakota G. R. Scott Budinger Kirtee Raparia Zenshiro Tamaki John Varga

The factors responsible for maintaining persistent organ fibrosis in systemic sclerosis (SSc) are not known but emerging evidence implicates toll-like receptors (TLRs) in the pathogenesis of SSc. Here we show the expression, mechanism of action and pathogenic role of endogenous TLR activators in skin from patients with SSc, skin fibroblasts, and in mouse models of organ fibrosis. Levels of tena...

Journal: :Clinical and experimental dermatology 2008
K Komura K Yanaba F Ogawa K Shimizu K Takehara S Sato

It is unclear whether any clinical and laboratory features are associated with pulmonary fibrosis (PF) in systemic sclerosis (SSc). We assessed these features using a database of 29 patients with SSc and anti-topoisomerase I antibodies and 68 patients with SSc and anticentromere antibody (ACA). Clinical features were not associated with the incidence of PF in patients with SSc and anti-topoisom...

Journal: :Clinical and experimental rheumatology 2008
T Yamaoka F Ogawa E Muroi T Hara K Komura Y Iwata M Takenaka K Shimizu M Hasegawa M Fujimoto S Sato

BACKGROUND Systemic sclerosis (SSc) is characterized by autoantibodies against various cellular components. OBJECTIVE To determine the presence or levels of antibodies (Abs) against a protease domain (PD) of caspase-8 and their clinical relevance in SSc. METHODS Anti-caspase-8 PD Ab was examined by enzyme-linked immunosorbent assay and immunoblotting using human recombinant caspase-8 PD. Ca...

2016
Björn Hegner Theres Schaub Rusan Catar Angelika Kusch Philine Wagner Kirill Essin Claudia Lange Gabriela Riemekasten Duska Dragun

INTRODUCTION Obliterative vasculopathy and fibrosis are hallmarks of systemic sclerosis (SSc), a severe systemic autoimmune disease. Bone marrow-derived mesenchymal stromal cells (MSCs) from SSc patients may harbor disease-specific abnormalities. We hypothesized disturbed vascular smooth muscle cell (VSMC) differentiation with increased propensity towards myofibroblast differentiation in respon...

Journal: :American journal of physiology. Gastrointestinal and liver physiology 2009
Jagmohan Singh Vaibhav Mehendiratta Francesco Del Galdo Sergio A Jimenez Sidney Cohen Anthony J DiMarino Satish Rattan

Systemic sclerosis (SSc) IgGs affecting the M(3)-muscarinic receptor (M(3)-R) have been proposed to be responsible for the gastrointestinal (GI) dysmotility in this disease. However, the effect of SSc IgGs on smooth muscle cell (SMC) function has not been studied. We determined the effect of SSc IgGs on the muscarinic receptor activation by bethanechol (BeCh; methyl derivate of carbachol) in SM...

Journal: :Rheumatology 2007
G Szücs Z Szekanecz E Zilahi A Kapitány S Baráth S Szamosi A Végvári Z Szabó S Szántó L Czirják C György Kiss

OBJECTIVE To determine the genetic, clinical and serological characteristics of systemic sclerosis (SSc)-rheumatoid arthritis (RA) overlap syndrome. METHODS Clinical manifestations and immunolaboratory features of 22 SSc-RA patients were assessed. The HLA-DR genotype of the 22 SSc-RA patients determined by SSP-PCR was compared with that of 38 SSc patients, 100 RA patients and 50 healthy contr...

Journal: :Annals of the rheumatic diseases 2017
Otylia Kowal-Bielecka Jaap Fransen Jerome Avouac Mike Becker Agnieszka Kulak Yannick Allanore Oliver Distler Philip Clements Maurizio Cutolo Laszlo Czirjak Nemanja Damjanov Francesco Del Galdo Christopher P Denton Jörg H W Distler Ivan Foeldvari Kim Figelstone Marc Frerix Daniel E Furst Serena Guiducci Nicolas Hunzelmann Dinesh Khanna Marco Matucci-Cerinic Ariane L Herrick Frank van den Hoogen Jacob M van Laar Gabriela Riemekasten Richard Silver Vanessa Smith Alberto Sulli Ingo Tarner Alan Tyndall Joep Welling Frederic Wigley Gabriele Valentini Ulrich A Walker Francesco Zulian Ulf Müller-Ladner

The aim was to update the 2009 European League against Rheumatism (EULAR) recommendations for the treatment of systemic sclerosis (SSc), with attention to new therapeutic questions. Update of the previous treatment recommendations was performed according to EULAR standard operating procedures. The task force consisted of 32 SSc clinical experts from Europe and the USA, 2 patients nominated by t...

2010
Maurizio Cutolo Alberto Sulli Carmen Pizzorni Vanessa Smith

Peripheral microvascular impairment in systemic sclerosis (SSc) may be easily detected and scored in a safe noninvasive way by nailfold videocapillaroscopy (NVC). The paper highlights clinical conditions related to SSc in which NVC may represent an outcome measure of therapeutical interventions, by elaborating on their already assessed relationship with the NVC patterns and eventually scores. T...

2011
Mirko Manetti Serena Guiducci Eloisa Romano Claudia Ceccarelli Silvia Bellando-Randone Maria Letizia Conforti Lidia Ibba-Manneschi Marco Matucci-Cerinic

VEGF165b were significantly higher in patients with SSc than in control subjects. Microvascular endothelial cells (MVECs) isolated from SSc skin expressed and released higher levels of VEGF165b than healthy MVECs. Transforming growth factor1 upregulated the expression of VEGF165b and serine/arginine protein 55 in both SSc and healthy MVECs. In SSc MVECs, VEGF receptor-2 was overexpressed, but i...

2011
Ann J. Impens Kristine Phillips Elena Schiopu

Systemic sclerosis- (SSc-) related vasculopathy, as manifested by Raynaud's Phenomenon (RP) and digital ulcers (DUs), is associated with significant impairment of the quality of life and morbidity. The current vasoactive approach for SSc-RP, although employing vasodilators, is entirely off-label. PDE-5 inhibitors improve peripheral circulation, are well tolerated, and are widely used for variou...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید